PVRIG Activators comprise a diverse group of chemicals that can influence the activity of the PVRIG protein, a receptor playing an integral role in the immune system, specifically within the realm of T cell response. These activators work by impacting various pathways or processes that relate to or surround PVRIG's functionality.
A notable example from this class is Phorbol Myristate Acetate (PMA), a compound recognized for its capability to activate protein kinase C, a key player in T cell activation processes. In tandem, Ionomycin can raise intracellular calcium levels, acting as a complementary force to PMA in driving T cell activation, which in turn affects PVRIG's function. On the other hand, substances like Cyclosporin A modulate T cell activation, casting implications on proteins like PVRIG. The list also features specialized inhibitors such as Okadaic Acid, Bisindolylmaleimide I, LY294002, U0126, Wortmannin, PD98059, and SB203580. Each of these compounds holds the power to target and inhibit specific enzymes or pathways central to T cell signaling.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA can activate protein kinase C, which is involved in T cell activation processes. This can indirectly influence PVRIG function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin raises intracellular calcium levels, complementing the action of PMA in T cell activation, potentially affecting PVRIG's role. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
An immunosuppressive agent that inhibits T cell activation, indirectly affecting proteins like PVRIG. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a key component in T cell activation. This can have implications for proteins like PVRIG. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A serine/threonine phosphatase inhibitor which can influence T cell signaling, potentially modulating PVRIG's activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A protein kinase C inhibitor that affects T cell activation and can indirectly modulate PVRIG function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can modulate T cell signaling and, by extension, potentially affect PVRIG activity. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Another PI3K inhibitor which can impact T cell activation, having potential implications for PVRIG. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits the activation of MAPK, which is involved in T cell signaling, and can indirectly influence PVRIG. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, which modulates T cell activation processes and can indirectly affect PVRIG activity. | ||||||